Treatment of bladder and gastrointestinal mastocytosis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01) A61K 38/43 (2006.01) A61K 38/54 (2006.01) A61K 38/55 (2006.01) A61K 38/57 (2006.01) C07K 14/00 (2006.01)

Patent

CA 2383486

The present invention provides for the treatment of an individual suffering from bladder or gastrointestinal mastocytosis utilizing a serine protease inhibitor. The treatment includes the use of a corticosteroid that is administered separately or in combination. The serine proteases preferred are alpha 1-antitrypsin and secretory leucocyte protease inhibitor.

Cette invention permet de traiter un individu souffrant de mastocytose gastro-intestinale ou de la vessie à l'aide d'un inhibiteur de sérine-protéase. Ce traitement consiste à utiliser un corticostéroïde qui est administré séparément ou de manière combinée. Les sérine-protéases préférées consistent en de la 1-antitrypsine alpha et en un inhibiteur de protéase de leucocyte sécrétoire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of bladder and gastrointestinal mastocytosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of bladder and gastrointestinal mastocytosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of bladder and gastrointestinal mastocytosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1350188

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.